Prasinezumab, CAS 1960462-19-4

Product Description: Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research[1].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]Gennaro Pagano, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021 Oct 1;12:705407.

CAS Number: 1960462-19-4

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: α-synuclein

• Artikelnummer: MEXHY-P99405-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99405-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK